Literature DB >> 10835094

Prolonged hepatitis B surface antigenemia after vaccination.

E R Lunn1, B J Hoggarth, W J Cook.   

Abstract

Infection with hepatitis B virus can lead to serious long-term complications including chronic hepatitis B virus infection leading to hepatocellular carcinoma, liver failure, and death. We report a case of prolonged hepatitis B antigenemia after routine vaccination with Engerix B. A positive hepatitis B surface antigen was found when the individual donated blood 18 days after vaccination. This resulted in rejection of the donated blood and permanent deferral from further donation. It also led to referral to a physician, creating anxiety in the individual and additional unnecessary testing. Additional studies are needed to identify the length to time of hepatitis B surface antigenemia after hepatitis B vaccination, and blood collection centers should be aware of the potential for donors to have a prolonged false-positive hepatitis B surface antigen after vaccination against hepatitis B. hepatitis B, hepatitis B vaccine, hepatitis B surface antigen, vaccine-induced positive hepatitis B surface antigen, Engerix B.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10835094     DOI: 10.1542/peds.105.6.e81

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  11 in total

Review 1.  The underlying mechanisms for the "isolated positivity for the hepatitis B surface antigen (HBsAg)" serological profile.

Authors:  Robério Amorim de Almeida Pondé
Journal:  Med Microbiol Immunol       Date:  2010-05-11       Impact factor: 3.402

2.  Highly sensitive detection of hepatitis B virus surface antigen by use of a semiautomated immune complex transfer chemiluminescence enzyme immunoassay.

Authors:  Kazuhiko Takeda; Mari Maruki; Takahiro Yamagaito; Machiko Muramatsu; Yasuhiro Sakai; Hiroaki Tobimatsu; Hironori Kobayashi; Yoshiteru Mizuno; Yukio Hamaguchi
Journal:  J Clin Microbiol       Date:  2013-05-08       Impact factor: 5.948

3.  Redefining an Optimal Donor Deferral Period following Hepatitis B Immunization.

Authors:  Manish Raturi; Shamee Shastry; Dhivya Kandasamy
Journal:  Indian J Hematol Blood Transfus       Date:  2018-05-11       Impact factor: 0.900

4.  Tissue inhibitor of matrix-metalloprotease-1 predicts risk of hepatic fibrosis in human Schistosoma japonicum infection.

Authors:  Valeria Fabre; Haiwei Wu; Sunthorn PondTor; Hannah Coutinho; Luz Acosta; Mario Jiz; Remigio Olveda; Ling Cheng; Eric S White; Blanca Jarilla; Stephen T McGarvey; Jennifer F Friedman; Jonathan D Kurtis
Journal:  J Infect Dis       Date:  2011-01-03       Impact factor: 5.226

5.  Hepatitis B Vaccine Coverage and the Immune Response in Children under ten years old in Sana'a, Yemen.

Authors:  Hassan A Al-Shamahy; Samira H Hanash; Iqbal A Rabbad; Nameem M Al-Madhaji; Samarih M Naser
Journal:  Sultan Qaboos Univ Med J       Date:  2011-02-12

6.  Health of children adopted from Ethiopia.

Authors:  Laurie C Miller; Beverly Tseng; Linda G Tirella; Wilma Chan; Emily Feig
Journal:  Matern Child Health J       Date:  2007-08-22

7.  False positive Hepatitis B Surface Antigen due to recent vaccination.

Authors:  Qudsia Anjum
Journal:  Int J Health Sci (Qassim)       Date:  2014-04

8.  Promoting improved utilization of laboratory testing through changes in an electronic medical record: experience at an academic medical center.

Authors:  Matthew D Krasowski; Deborah Chudzik; Anna Dolezal; Bryan Steussy; Michael P Gailey; Benjamin Koch; Sara B Kilborn; Benjamin W Darbro; Carolyn D Rysgaard; Julia A Klesney-Tait
Journal:  BMC Med Inform Decis Mak       Date:  2015-02-22       Impact factor: 2.796

9.  Vaccination and transient hepatitis B surface antigenemia.

Authors:  Dhanya Mohan; Mohammed Railey; Mona Al Rukhaimi
Journal:  NDT Plus       Date:  2011-03-17

10.  Transient Hepatitis B Surface Antigenemia Following Immunization with Heplisav-B.

Authors:  Cristina Corsini Campioli; Zerelda Esquer Garrigos; Mariam Assi; John Raymond Go; Raymund R Razonable; Elena Beam; Joseph Yao; Nathan W Cummins
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2021-01-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.